BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 11, 2003
View Archived Issues
A high dose of ximelagatran better than warfarin in preventing DVT after total knee replacement
Read More
Cognitive and functional improvements associated with donepezil in vascular dementia
Read More
Improved quality of life seen in SLE patients treated with LJP-394
Read More
Good cardiovascular safety profile described for ospemifene in postmenopausal women
Read More
New inhibitors of VLA-4-mediated cell adhesion developed at Toray
Read More
Durable antiviral response induced by tipranavir in heavily pretreated HIV patients
Read More
Antiviral activity and pharmacokinetics of SPD-754 in HIV infection
Read More
Novel histamine H1 antagonists under study at Almirall Prodesfarma
Read More
Pfizer patent covers new NS5B inhibitors with potential in HCV infection
Read More
BMS researchers present new protein kinase inhibitors for proliferative and inflammatory disorders
Read More
New ErbB kinase inhibitors, their preparation and use revealed in AstraZeneca patent
Read More
Ajinomoto presents novel benzodiazepine-based factor Xa inhibitors
Read More
Banyu team identifies new glucokinase activators
Read More
Indian scientists claim new antibacterial oxazolidinones in recent patent
Read More
CAP delivery system extends duration of insulin action in preclinical study
Read More
Lysostaphin eradicates MRSA biofilms on artificial surfaces
Read More
Hybrigenics and Servier sign new drug discovery agreements
Read More
Lexicon moves into ophthalmology
Read More
Maxim seeks European approval for Ceplene treatment
Read More
Enrollment under way for phase IIb obesity study of AOD-9604
Read More
Chiron grants Vertex HCV license
Read More
Phase I trial commences for Oxycyte
Read More
Specific VRAC inhibitor with antiarrhythmic effects presented in Orlando
Read More
Inhibition of malonyl-CoA decarboxylase modulates fatty acid oxidation in rat hearts
Read More
LXR agonist ATI-829 increases brain apo E in vitro and in vivo
Read More
AR-10A exhibits a suitable profile for further development as an antiobesity agent
Read More
JNJ-17153656, a dual delta/mu opioid receptor agonist for GI disorders
Read More